Up to ten percent of cancers are due to factors that are passed from one generation to the next. These syndromes are known as hereditary cancers, and there are certain genetic tests that can determine an individual’s risk for these cancers. If you have reason to suspect that you or someone you know may be at risk for cancer, such as a family history of cancer, membership in an at-risk ethnic population, or other factors, we encourage genetic testing among individuals so that they can take action, preventing cancer to live longer healthier lives.
The BRAC Analysis gene test is a blood test that uses DNA analysis to identify harmful changes (mutations) in either one of the two breast cancer susceptibility genes — BRCA1 and BRCA2. Women who have inherited mutations in these genes face a much higher risk of developing breast cancer and ovarian cancer compared with the general population. After having a BRAC Analysis gene test performed, you learn whether you carry an inherited BRAC Analysis gene mutation and receive an estimate of your personal risk of breast cancer and ovarian cancer.
BRAC Analysis Large Rearrangement Test (BART)
Comprehensive BRAC Analysis® is a highly reliable and accurate test that includes complete sequencing of the BRCA1 and BRCA2 genes and an additional procedure to identify five common large rearrangements in the BRCA1 gene.
The BRAC Analysis Large Rearrangement Test (BART) was launched to provide a way to detect additional large genomic rearrangements in both BRCA1 and BRCA2.
The Center for Age Management Offers Both the BRAC Analysis AND BART TESTING.